1. Home
  2. AAT vs OGN Comparison

AAT vs OGN Comparison

Compare AAT & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Assets Trust Inc.

AAT

American Assets Trust Inc.

HOLD

Current Price

$22.77

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.72

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAT
OGN
Founded
1967
1923
Country
United States
United States
Employees
208
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
AAT
OGN
Price
$22.77
$13.72
Analyst Decision
Sell
Hold
Analyst Count
2
5
Target Price
$19.50
$11.40
AVG Volume (30 Days)
388.5K
2.6M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
6.65%
0.60%
EPS Growth
N/A
N/A
EPS
0.08
0.95
Revenue
$436,204,000.00
$6,216,000,000.00
Revenue This Year
$4.33
$0.45
Revenue Next Year
$0.22
$1.67
P/E Ratio
$287.00
$14.44
Revenue Growth
N/A
N/A
52 Week Low
$17.72
$5.69
52 Week High
$25.97
$13.72

Technical Indicators

Market Signals
Indicator
AAT
OGN
Relative Strength Index (RSI) 39.12 75.31
Support Level $18.23 $13.46
Resistance Level $25.76 N/A
Average True Range (ATR) 0.52 0.04
MACD -0.10 0.01
Stochastic Oscillator 23.43 97.50

Price Performance

Historical Comparison
AAT
OGN

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: